2 April - 4 April 2025

41st SCI Process Development Symposium

Organised by:

SCI's Fine Chemicals Group

Churchill College, Cambridge, UK

Register your interest
Synopsis
Process Development is the application of chemistry to the scale up of new synthetic processes from the laboratory, through pilot plant to full scale commercial manufacture and into life cycle management. It is an extremely broad discipline, crossing the boundaries between synthetic organic chemistry, process technology and chemical engineering.
The area of Process Development continues to be a challenging and important area for the research into and application of modern synthetic organic chemistry, as well as enabling technologies. 
 

Attendees
The symposium aims to bring together a wide range of speakers from across the Pharmaceutical, Agrochemical and Fine Chemical industries, as well as from an academic background. This meeting brings together experts from across the entire spectrum of the discipline to present state of the art process development.
Sponsorship and Exhibitor information

For further information and prices, please email conferences@soci.org.


Programme

The programme will be confirmed in due course.


Accessibility Grants

SCI accessibility grants are available to support SCI members with disabilities, long term health conditions, those who require a carer, and members who are nursing parents to attend SCI events. Download an application form to apply for a grant.


Venue and Contact

Churchill College

Storey's Way
Cambridge
CB3 0DS

Conference Team

Tel: +44 (0)20 7598 1561

Email: conferences@soci.org


Booking Process/Deadlines

Booking terms and conditions


CPD Info

SCI Members attending this meeting are able to claim CPD points.

Accredited cpd Centre - The CPD Standards Office - CPD Provider 41057 - www.cpdstandards.com


Organising committee
Max Espensen, SCI/Pharmaron
Richard Horan, SCI/GlaxoSmithKline
Dave Lathbury, SCI/Astute Chemical Development Ltd
Peter Quinn, Syngenta
Robert Walton, SCI
Hilmar Weinman, Janssen Pharmaceutical Companies of Johnson & Johnson